Using scenarios to test the appropriateness of pharmacist prescribing in asthma management

Abstract

ObjectiveTo explore the potential for community pharmacist prescribing in terms of usefulness, pharmacists’ confidence, and appropriateness, in the context of asthma management. MethodsTwenty community pharmacists were recruited using convenience sampling from a group of trained practitioners who had already delivered asthma services. These pharmacists were asked to complete a scenario-based questionnaire (9 scenarios) modelled on information from real patients. Pharmacist interventions were independently reviewed and rated on their appropriateness according to the Respiratory Therapeutic Guidelines (TG) by three expert researchers.ResultsIn seven of nine scenarios (78%), the most common prescribing intervention made by pharmacists agreed with TG recommendations. Although the prescribing intervention was appropriate in the majority of cases, the execution of such interventions was not in line with guidelines (i.e. dosage or frequency) in the majority of scenarios. Due to this, only 47% (76/162) of the interventions overall were considered appropriate. However, pharmacists were deemed to be often following common clinical practice for asthma prescribing. Therefore 81% (132/162) of prescribing interventions were consistent with clinical practice, which is often not guideline driven, indicating a need for specific training in prescribing according to guidelines. Pharmacists reported that they were confident in making prescribing interventions and that this would be very useful in their management of the patients in the scenarios.ConclusionsCommunity pharmacists may be able to prescribe asthma medications appropriately to help achieve good outcomes for their patients. However, further training in the guidelines for prescribing are required if pharmacists are to support asthma management in this way.

Exploring the potential for pharmacist prescribing in the management of hypertension in primary care: an Australian survey

“…This aligns with previous research targeting the management of chronic diseases by pharmacists (i.e. asthma) . It also supports previous research exploring the perspectives of a broad range of Australian pharmacists (including accredited pharmacists), which reported strongest support for an expanded prescribing role in hypertension management among a select range of chronic conditions .…”

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences

“…Australian researchers have explored stakeholders’ perceptions and outcomes of PP, and education and training requirements for expanding pharmacists’ scope of practice . Pharmacists and patients indicated support for supplementary rather than IP roles, due to concerns about PP competence .…”

“…Pharmacists and patients indicated support for supplementary rather than IP roles, due to concerns about PP competence . The positive effect of supplementary PP and the competence of pharmacist prescribers have been verified in clinical trials and assisted training to support this expanded scope has been identified . No published studies have explored barriers to the extension of prescribing rights to Australian pharmacists.…”

Management of hypertension in an Australian community pharmacy setting – patients’ beliefs and perspectives

“…[6][7][8] In the primary care setting, the community pharmacy is the most accessible health service; indeed, patients generally visit the community pharmacist more often than their general practitioner (GP), particularly if they have chronic conditions requiring refills of prescription medicines. [12][13][14][15] However, few services are explicitly multifaceted, targeting both the patient's adherence and the clinician's prescribing. [12][13][14][15] However, few services are explicitly multifaceted, targeting both the patient's adherence and the clinician's prescribing.…”